JAK Inhibitor News and Research

RSS
CHLA launches first clinical trial for Down syndrome regression disorder with $5.3 million NIH grant

CHLA launches first clinical trial for Down syndrome regression disorder with $5.3 million NIH grant

Study reviews mechanistic data on new methods of allergy prevention and treatment

Study reviews mechanistic data on new methods of allergy prevention and treatment

Does skin inflammation exacerbate COVID-19?

Does skin inflammation exacerbate COVID-19?

Antibody drugs are not recommended for patients with covid-19, say WHO experts

Antibody drugs are not recommended for patients with covid-19, say WHO experts

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Oral pill taken once a day improves outcomes of patients with myelofibrosis

Oral pill taken once a day improves outcomes of patients with myelofibrosis

Cycling JAK inhibitors can be effective for treating people with difficult-to-treat rheumatoid arthritis

Cycling JAK inhibitors can be effective for treating people with difficult-to-treat rheumatoid arthritis

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

Autoimmune condition biomarkers promote SARS-CoV-2 viral entry, study finds

Autoimmune condition biomarkers promote SARS-CoV-2 viral entry, study finds

Novel super-activating macrophage receptor could explain hyper-inflammation in severe COVID-19

Novel super-activating macrophage receptor could explain hyper-inflammation in severe COVID-19

Study shows  tofacitinib drug can repair permeability defects in the intestine

Study shows tofacitinib drug can repair permeability defects in the intestine

Researchers discover treatment for severe auto inflammatory syndrome

Researchers discover treatment for severe auto inflammatory syndrome

Insilico Medicine, Arctoris announce technology partnership to discover new COVID-19 drugs

Insilico Medicine, Arctoris announce technology partnership to discover new COVID-19 drugs

Could JAK blockers help treat COVID-19?

Could JAK blockers help treat COVID-19?

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

Study adds more evidence to underlying autoimmune mechanisms in type 1 diabetes

Study adds more evidence to underlying autoimmune mechanisms in type 1 diabetes

New treatment option could provide effective therapy for patients with dermatologic conditions

New treatment option could provide effective therapy for patients with dermatologic conditions

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

Research finding opens door to new treatment options for inflammatory rheumatism

Research finding opens door to new treatment options for inflammatory rheumatism